MedPath

Evaluation of Emergency Suturing with Absorbable Versus Non-absorbable Suture Material in a Pediatric Population

Not Applicable
Active, not recruiting
Conditions
Wounds and Injuries
Interventions
Device: Absorbable
Device: Non absorbable
Registration Number
NCT02777346
Lead Sponsor
Pediatric Clinical Research Platform
Brief Summary

The investigators recruit patients admitted to the Pediatric Emergency Department of the Geneva's University Hospital with open wounds needing suture. The patients are treated with absorbable versus non-absorbable suture material according to randomization.

Outcomes are:

1. infection rate at the first follow-up (between 4 and 14 days, depending on the sutured site and defined by protocol)

2. scar appearance at a 6-months follow-up.

Detailed Description

The investigators recruit patients admitted to the Pediatric Emergency Department of the Geneva's University Hospital with open wounds needing suture. The patients are treated with absorbable versus non-absorbable suture material according to randomization.

After obtaining the patient's/parent's consent and randomization, the suture material will be provided.

Selection of the size of the thread and the date of the first follow-up are determined as follows:

* Face: Thread size 5-0 to 7-0, first follow-up 4-7 days

* Torso/back: Thread size 4-0 or 5-0, first follow-up 10-14 days

* Arms: Thread size 4-0 or 5-0, first follow-up 7- 10 days

* Hand: Thread size 5-0 or 6-0, first follow-up 7-10 days

* Legs: Thread size 4-0 or 5-0, first follow-up 7-14 days

The patients are examined by in the outpatient wound clinic by specialised nurses under medical supervision at the first follow-up, and at six months by one of the investigators.

Outcomes:

1. infection rate at the first follow-up (between 4 and 14 days, depending on the sutured site and defined by protocol)

2. scar appearance at a 6-months follow-up.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
500
Inclusion Criteria
  • Patient younger than 16 years of age with a wound requiring suture
Exclusion Criteria
  • Deep wounds with lesions of subcutaneous structures (tendons, nerves, etc.)
  • Wounds with tissue loss
  • Diabetic patients or patients treated with drugs potentially compromising cicatrization (e.g. steroids, immunosuppressors, etc.)
  • Wounds caused by animal or human bites
  • Sutures not performed in the emergency room
  • Heavily soiled wounds

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
AbsorbableAbsorbableSuture material: Polyglactin 910 thread (Vicryl Rapide®, Ethicon Inc).
Non AbsorbableNon absorbableSuture material: Polypropylene thread (Prolene®, Ethicon Inc).
Primary Outcome Measures
NameTimeMethod
Short-term infection risk4 to 21 days

Scars classified as "no evidence of infection", "signs of inflammation" and "signs of active infection"

Secondary Outcome Measures
NameTimeMethod
Scar appearance6 months

Scoring based on the Manchester scar scale

Trial Locations

Locations (1)

Geneva University Hospital

🇨🇭

Geneve, Genève, Switzerland

© Copyright 2025. All Rights Reserved by MedPath